Matches in SemOpenAlex for { <https://semopenalex.org/work/W2084751356> ?p ?o ?g. }
- W2084751356 endingPage "293" @default.
- W2084751356 startingPage "273" @default.
- W2084751356 abstract "Background: Acromegaly is due to growth hormone (GH) hypersecretion by a benign pituitary tumor (adenoma). Treatments include surgical removal of the adenoma (often incomplete when the tumor is large and/or invasive), radiotherapy of the pituitary region (sometimes effective only after > 10 years, and potentially causing cerebrovascular disease), and medical therapy. Methods: The scope of this article is to review the efficacy and safety of currently marketed drugs and to discuss the interest of new compounds. For this purpose, critical analysis of original articles and reviews was made and manufacturers were asked to provide all data that have been presented in congress and are not yet published. Results/conclusion: Somatostatin analogs (first octreotide and then lanreotide) have been used for 20 years to treat patients in whom surgery and/or radiotherapy has failed, and also as first-line therapy when other modalities are contraindicated or are unlikely to control GH and insulin-like growth factor-I (IGF-I) hypersecretion. Long-lasting formulations, requiring only one monthly injection, have greatly improved the convenience of these treatments. GH/IGF-I hypersecretion is controlled by these drugs in about 50% of patients, but the remaining patients require another treatment. Pegvisomant, a drug belonging to a totally different therapeutic class (GH-receptor antagonists) with a different mode of action, is effective in most of these patients. According to current research goals, new developmental drugs include new somatostatin analogs (SAs) with different somatostatin receptor selectivity, and chimeric molecules that are able to bind to both somatostatin and dopamine receptors." @default.
- W2084751356 created "2016-06-24" @default.
- W2084751356 creator A5028728211 @default.
- W2084751356 date "2008-06-01" @default.
- W2084751356 modified "2023-09-24" @default.
- W2084751356 title "Emerging drugs for acromegaly" @default.
- W2084751356 cites W115663412 @default.
- W2084751356 cites W123434114 @default.
- W2084751356 cites W1573871019 @default.
- W2084751356 cites W1862508240 @default.
- W2084751356 cites W190592843 @default.
- W2084751356 cites W1967226362 @default.
- W2084751356 cites W1969665744 @default.
- W2084751356 cites W1974656027 @default.
- W2084751356 cites W1975874471 @default.
- W2084751356 cites W1981382809 @default.
- W2084751356 cites W1982178657 @default.
- W2084751356 cites W1987457359 @default.
- W2084751356 cites W1988395319 @default.
- W2084751356 cites W1988701052 @default.
- W2084751356 cites W1993733299 @default.
- W2084751356 cites W1997012826 @default.
- W2084751356 cites W1997194267 @default.
- W2084751356 cites W1998795762 @default.
- W2084751356 cites W1999435729 @default.
- W2084751356 cites W1999552666 @default.
- W2084751356 cites W2000449314 @default.
- W2084751356 cites W2002070825 @default.
- W2084751356 cites W2004483751 @default.
- W2084751356 cites W2005101313 @default.
- W2084751356 cites W2006199127 @default.
- W2084751356 cites W2006611896 @default.
- W2084751356 cites W2006741013 @default.
- W2084751356 cites W2008178390 @default.
- W2084751356 cites W2009323605 @default.
- W2084751356 cites W2010772266 @default.
- W2084751356 cites W2014729851 @default.
- W2084751356 cites W2018042027 @default.
- W2084751356 cites W2025569597 @default.
- W2084751356 cites W2025997743 @default.
- W2084751356 cites W2026113062 @default.
- W2084751356 cites W2026608995 @default.
- W2084751356 cites W2028425454 @default.
- W2084751356 cites W2035030554 @default.
- W2084751356 cites W2040054585 @default.
- W2084751356 cites W2040844989 @default.
- W2084751356 cites W2044919174 @default.
- W2084751356 cites W2045244724 @default.
- W2084751356 cites W2045645101 @default.
- W2084751356 cites W2045942594 @default.
- W2084751356 cites W2049500658 @default.
- W2084751356 cites W2049558521 @default.
- W2084751356 cites W2057835402 @default.
- W2084751356 cites W2058560205 @default.
- W2084751356 cites W2059027605 @default.
- W2084751356 cites W2061729174 @default.
- W2084751356 cites W2061834810 @default.
- W2084751356 cites W2066190724 @default.
- W2084751356 cites W2069597616 @default.
- W2084751356 cites W2069832931 @default.
- W2084751356 cites W2072352723 @default.
- W2084751356 cites W2072997411 @default.
- W2084751356 cites W2079846716 @default.
- W2084751356 cites W2079869308 @default.
- W2084751356 cites W2080232093 @default.
- W2084751356 cites W2084898691 @default.
- W2084751356 cites W2088031764 @default.
- W2084751356 cites W2088653136 @default.
- W2084751356 cites W2090051214 @default.
- W2084751356 cites W2099339964 @default.
- W2084751356 cites W2102043567 @default.
- W2084751356 cites W2102303758 @default.
- W2084751356 cites W2103938643 @default.
- W2084751356 cites W2104254929 @default.
- W2084751356 cites W2106242215 @default.
- W2084751356 cites W2111216596 @default.
- W2084751356 cites W2112309011 @default.
- W2084751356 cites W2113785862 @default.
- W2084751356 cites W2114461739 @default.
- W2084751356 cites W2114607990 @default.
- W2084751356 cites W2116114460 @default.
- W2084751356 cites W2117099801 @default.
- W2084751356 cites W2117270119 @default.
- W2084751356 cites W2117369752 @default.
- W2084751356 cites W2118341413 @default.
- W2084751356 cites W2119094244 @default.
- W2084751356 cites W2119964908 @default.
- W2084751356 cites W2123601063 @default.
- W2084751356 cites W2126750918 @default.
- W2084751356 cites W2126933407 @default.
- W2084751356 cites W2128279262 @default.
- W2084751356 cites W2130644916 @default.
- W2084751356 cites W2131228526 @default.
- W2084751356 cites W2131231109 @default.
- W2084751356 cites W2132094049 @default.
- W2084751356 cites W2134166265 @default.
- W2084751356 cites W2134282876 @default.
- W2084751356 cites W2134378936 @default.